A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells
1998

Melatonin and Retinoic Acid Induce Apoptosis in Breast Cancer Cells

publication Evidence: moderate

Author Information

Author(s): KM Eck, L Yuan, L Duffy, PT Ram, S Ayettey, I Chen, CS Cohn, JC Reed, SM Hill

Primary Institution: Tulane University School of Medicine

Hypothesis

Does a sequential treatment regimen with melatonin and all-trans retinoic acid induce apoptosis in MCF-7 tumor cells?

Conclusion

The sequential treatment with melatonin followed by all-trans retinoic acid effectively induces apoptosis in hormone-responsive breast cancer cells.

Supporting Evidence

  • The sequential treatment resulted in a complete cessation of cell growth in MCF-7 cells.
  • Apoptosis was evidenced by morphological changes and increased expression of pro-apoptotic factors.
  • ER-negative breast cancer cells did not respond to the sequential treatment.

Takeaway

This study found that giving melatonin and retinoic acid one after the other can help kill certain breast cancer cells.

Methodology

The study used MCF-7 and T47D breast cancer cell lines to test the effects of melatonin and retinoic acid on cell proliferation and apoptosis.

Limitations

The study was conducted only in cultured cells, and results may differ in human tumors.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication